Stephanie Ruth Young, Julia Yoshino Benavente, Elizabeth McManus Dworak, Michael S Wolf, Cindy J Nowinski
{"title":"Adaptive testing for smartphone-based cognitive screening: Reducing patient burden while maintaining classification accuracy.","authors":"Stephanie Ruth Young, Julia Yoshino Benavente, Elizabeth McManus Dworak, Michael S Wolf, Cindy J Nowinski","doi":"10.1002/dad2.70455","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Remote cognitive screening for primary care must balance accuracy with patient burden. We evaluated whether adaptive task administration could reduce testing while preserving classification accuracy.</p><p><strong>Methods: </strong>Using data from older adults (<i>N</i> = 277; 100 mild cognitive impairment [MCI]; 177 normal cognitive aging) who self-administered MyCog Mobile, we developed a stepped protocol in which the final task is skipped when preceding tasks classify the patient with confidence. Leave-one-out cross-validation (LOO-CV) assessed agreement with the full-battery classification and accuracy relative to the reference diagnosis.</p><p><strong>Results: </strong>Thirty-three percent of participants were classified at the initial decision point, and only 17% required the full battery. LOO-CV showed a negligible change in area under the curve (ΔAUC = 0.008; bootstrapped 95% confidence interval [-0.004, 0.021]) using the adaptive battery.</p><p><strong>Discussion: </strong>Approximately one third of older adults can be accurately classified as with MCI using only two MyCog Mobile tasks under an adaptive approach. Prospective validation, in which the adaptive battery is administered in real time, is warranted.</p>","PeriodicalId":53226,"journal":{"name":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","volume":"18 3","pages":"e70455"},"PeriodicalIF":4.4000,"publicationDate":"2026-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13490832/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/dad2.70455","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Remote cognitive screening for primary care must balance accuracy with patient burden. We evaluated whether adaptive task administration could reduce testing while preserving classification accuracy.
Methods: Using data from older adults (N = 277; 100 mild cognitive impairment [MCI]; 177 normal cognitive aging) who self-administered MyCog Mobile, we developed a stepped protocol in which the final task is skipped when preceding tasks classify the patient with confidence. Leave-one-out cross-validation (LOO-CV) assessed agreement with the full-battery classification and accuracy relative to the reference diagnosis.
Results: Thirty-three percent of participants were classified at the initial decision point, and only 17% required the full battery. LOO-CV showed a negligible change in area under the curve (ΔAUC = 0.008; bootstrapped 95% confidence interval [-0.004, 0.021]) using the adaptive battery.
Discussion: Approximately one third of older adults can be accurately classified as with MCI using only two MyCog Mobile tasks under an adaptive approach. Prospective validation, in which the adaptive battery is administered in real time, is warranted.
期刊介绍:
Alzheimer''s & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access, peer-reviewed, journal from the Alzheimer''s Association® that will publish new research that reports the discovery, development and validation of instruments, technologies, algorithms, and innovative processes. Papers will cover a range of topics interested in the early and accurate detection of individuals with memory complaints and/or among asymptomatic individuals at elevated risk for various forms of memory disorders. The expectation for published papers will be to translate fundamental knowledge about the neurobiology of the disease into practical reports that describe both the conceptual and methodological aspects of the submitted scientific inquiry. Published topics will explore the development of biomarkers, surrogate markers, and conceptual/methodological challenges. Publication priority will be given to papers that 1) describe putative surrogate markers that accurately track disease progression, 2) biomarkers that fulfill international regulatory requirements, 3) reports from large, well-characterized population-based cohorts that comprise the heterogeneity and diversity of asymptomatic individuals and 4) algorithmic development that considers multi-marker arrays (e.g., integrated-omics, genetics, biofluids, imaging, etc.) and advanced computational analytics and technologies.